Direkt zum Inhalt
Merck

T3077

Sigma-Aldrich

TRO 19622

≥98% (HPLC), solid

Synonym(e):

NSC 21311, cholest-4-en-3-one, oxime

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise

Größe auswählen

5 MG
€ 152,00
25 MG
€ 662,00

€ 152,00


Voraussichtliches Versanddatum11. Mai 2025


Bulk-Bestellung anfordern

Größe auswählen

Ansicht ändern
5 MG
€ 152,00
25 MG
€ 662,00

About This Item

Empirische Formel (Hill-System):
C27H45NO
CAS-Nummer:
Molekulargewicht:
399.65
UNSPSC-Code:
12352200
NACRES:
NA.77

€ 152,00


Voraussichtliches Versanddatum11. Mai 2025


Bulk-Bestellung anfordern

Qualitätsniveau

Assay

≥98% (HPLC)

Form

solid

Farbe

white

Löslichkeit

DMSO: >10 mg/mL

Lagertemp.

−20°C

InChI

1S/C27H45NO/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28-29)13-15-26(20,4)25(22)14-16-27(23,24)5/h17-19,22-25,29H,6-16H2,1-5H3/b28-21+

InChIKey

QNTASHOAVRSLMD-SGWCAAJKSA-N

Anwendung

TRO 19622 has been used as a mitochondrial permeability transition pore inhibitor in mouse neurons2. TRO 19622 is also known to stimulate myelin repair in rat models of demyelination3.

Biochem./physiol. Wirkung

TRO 19622 can decrease axonal degradation and enhance the rescue of motor nerve conduction in peripheral neuropathy. Furthermore, TRO 19622 can reverse neuropathic pain and tactile allodynia in rat models of diabetes and chemotherapy-induced neuropathic pain4.
TRO19622 ia a neuroprotective agent for motor neurons; candidate therapeutic for amyotrophic lateral sclerosis (ALS).

Angaben zur Herstellung

TRO 19622 is soluble in DMSO at a concentration that is greater than 10 mg/ml.

Lagerklassenschlüssel

11 - Combustible Solids

WGK

WGK 3

Flammpunkt (°F)

Not applicable

Flammpunkt (°C)

Not applicable


Hier finden Sie alle aktuellen Versionen:

Analysenzertifikate (COA)

Lot/Batch Number

Die passende Version wird nicht angezeigt?

Wenn Sie eine bestimmte Version benötigen, können Sie anhand der Lot- oder Chargennummer nach einem spezifischen Zertifikat suchen.

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Lee J Martin et al.
The Journal of neuroscience : the official journal of the Society for Neuroscience, 31(1), 359-370 (2011-01-07)
Ablation of mouse occipital cortex induces precisely timed and uniform p53-modulated and Bax-dependent apoptosis of thalamocortical projection neurons in the dorsal lateral geniculate nucleus (LGN) by 7 d after lesion. We tested the hypothesis that this neuronal apoptosis is initiated
Lyudmila I Rachek et al.
Toxicology and applied pharmacology, 240(3), 348-354 (2009-07-28)
Thiazolidinediones (TZDs), such as troglitazone (TRO) and rosiglitazone (ROSI), improve insulin resistance by acting as ligands for the nuclear receptor peroxisome proliferator-activated receptor-gamma (PPARgamma). TRO was withdrawn from the market because of reports of serious hepatotoxicity. A growing body of
Thierry Bordet et al.
The Journal of pharmacology and experimental therapeutics, 322(2), 709-720 (2007-05-15)
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterized by progressive death of cortical and spinal motor neurons, for which there is no effective treatment. Using a cell-based assay for compounds capable of preventing motor neuron cell death in
Yiqiao Li et al.
The International journal of neuroscience, 123(11), 810-822 (2013-05-15)
Multiple sclerosis is a neurodegenerative autoimmune disease characterized by diffuse oligodendrocyte injury, axonal loss and multifocal demyelination of myelin sheaths in the central nervous system. TRO19622 is a small cholesterol-like compound, which displays remarkable neuroprotective and neuroregenerative properties in neural
Thierry Bordet et al.
The Journal of pharmacology and experimental therapeutics, 326(2), 623-632 (2008-05-22)
Diabetes and cancer chemotherapies are often associated with painful neuropathy. The mechanisms underlying neuropathic pain remain poorly understood, and the current therapies have limited efficacy and are associated with dose-limiting side effects. We recently described the pharmacological characterization of cholest-4-en-3-one

Questions

1–4 of 4 Questions  
  1. What is the solubility of TRO 19622, Product T3077?

    1 answer
    1. This compound is soluble in DMSO (> 10mg/ml).

      Helpful?

  2. What is the Department of Transportation shipping information for this product?

    1 answer
    1. Transportation information can be found in Section 14 of the product's (M)SDS.To access the shipping information for this material, use the link on the product detail page for the product.

      Helpful?

  3. What is the structure of TRO 19622, Product T3077?

    1 answer
    1. Please see the following reference for more information: T. Bordet et al., Identification and characterization of cholest-4-en-3-one, oxime (TRO19622), a novel drug candidate for amyotrophic lateral sclerosis. J. Pharmacol. Exp. Ther., 322, 709-720 (2007).

      Helpful?

  4. How does TRO 19622, Product T3077 work?

    1 answer
    1. TRO 19622 interacts with the mitochondrial permeability transition pore (mPTP).  By interacting with protein components of the mPTP, it prevents the release of apoptotic factors and therefore protects the neuron.  This mechanism of action may lead to a general neuroprotective activity.  Please see the following reference for more information: T. Bordet et al., Identification and characterization of cholest-4-en-3-one, oxime (TRO19622), a novel drug candidate for amyotrophic lateral sclerosis J. Pharmacol. Exp. Ther. 322, 709-720, (2007)

      Helpful?

Reviews

No rating value

Active Filters

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.